Implications of the differing roles of the β1 and β3 transmembrane and cytoplasmic domains for integrin function

  1. Zhenwei Lu
  2. Sijo Mathew
  3. Jiang Chen
  4. Arina Hadziselimovic
  5. Riya Palamuttam
  6. Billy G Hudson
  7. Reinhard Fässler
  8. Ambra Pozzi
  9. Charles R Sanders  Is a corresponding author
  10. Roy Zent  Is a corresponding author
  1. Vanderbilt University Medical Center, United States
  2. Vanderbilt Medical Center, United States
  3. Virginia Tech, United States
  4. Max Planck Institute of Biochemistry, Germany

Abstract

Integrins are transmembrane receptors composed of α and β subunits. Although most integrins contain β1, canonical activation mechanisms are based on studies of the platelet integrin, αIIbβ3. Its inactive conformation is characterized by association of the αIIb transmembrane and cytosolic domain (TM/CT) with a tilted β3 TM/CT that leads to activation when disrupted. We show significant structural differences between β1 and β3 TM/CT in bicelles. Moreover, the 'snorkeling' lysine at the TM/CT interface of β subunits, previously proposed to regulate αIIbβ3 activation by ion pairing with nearby lipids, plays opposite roles in β1 and β3 integrin function and in neither case is responsible for TM tilt. Affinities ranging from almost no interaction to the relatively high avidity that characterizes αIIbβ3 exist between various α subunits and β1 TM/CTs. The αIIbβ3-based canonical model for the roles of the TM/CT in integrin activation and function clearly does not extend to all mammalian integrins.

Article and author information

Author details

  1. Zhenwei Lu

    Department of Biochemistry, Vanderbilt University Medical Center, Nashville, United States
    Competing interests
    No competing interests declared.
  2. Sijo Mathew

    Division of Nephrology, Department of Medicine, Vanderbilt Medical Center, Nashville, United States
    Competing interests
    No competing interests declared.
  3. Jiang Chen

    Department of Biomedical Sciences and Pathobiology, Virginia Tech, Blacksburg, United States
    Competing interests
    No competing interests declared.
  4. Arina Hadziselimovic

    Department of Biochemistry, Vanderbilt University Medical Center, Nashville, United States
    Competing interests
    No competing interests declared.
  5. Riya Palamuttam

    Department of Biochemistry, Vanderbilt University Medical Center, Nashville, United States
    Competing interests
    No competing interests declared.
  6. Billy G Hudson

    Department of Biochemistry, Vanderbilt University Medical Center, Nashville, United States
    Competing interests
    No competing interests declared.
  7. Reinhard Fässler

    Department of Molecular Medicine, Max Planck Institute of Biochemistry, Martinsried, Germany
    Competing interests
    Reinhard Fässler, Reviewing editor, eLife.
  8. Ambra Pozzi

    Division of Nephrology, Department of Medicine, Vanderbilt University Medical Center, Nashville, United States
    Competing interests
    Ambra Pozzi, Reviewing editor, eLife.
  9. Charles R Sanders

    Department of Biochemistry, Vanderbilt University Medical Center, Nashville, United States
    For correspondence
    chuck.sanders@vanderbilt.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2046-2862
  10. Roy Zent

    Division of Nephrology, Department of Medicine, Vanderbilt University Medical Center, Nashville, United States
    For correspondence
    roy.zent@vanderbilt.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2983-8133

Funding

Veterans Affairs San Diego Healthcare System

  • Ambra Pozzi
  • Roy Zent

National Institutes of Health

  • Billy G Hudson
  • Ambra Pozzi
  • Charles R Sanders
  • Roy Zent

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2016, Lu et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,966
    views
  • 522
    downloads
  • 27
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Zhenwei Lu
  2. Sijo Mathew
  3. Jiang Chen
  4. Arina Hadziselimovic
  5. Riya Palamuttam
  6. Billy G Hudson
  7. Reinhard Fässler
  8. Ambra Pozzi
  9. Charles R Sanders
  10. Roy Zent
(2016)
Implications of the differing roles of the β1 and β3 transmembrane and cytoplasmic domains for integrin function
eLife 5:e18633.
https://doi.org/10.7554/eLife.18633

Share this article

https://doi.org/10.7554/eLife.18633

Further reading

    1. Biochemistry and Chemical Biology
    2. Cell Biology
    Julia Shangguan, Ronald S Rock
    Research Article

    Myosin 10 (Myo10) is a motor protein known for its role in filopodia formation. Although Myo10-driven filopodial dynamics have been characterized, there is no information about the absolute number of Myo10 molecules during the filopodial lifecycle. To better understand molecular stoichiometries and packing restraints in filopodia, we measured Myo10 abundance in these structures. We combined SDS-PAGE densitometry with epifluorescence microscopy to quantitate HaloTag-labeled Myo10 in U2OS cells. About 6% of total intracellular Myo10 localizes to filopodia, where it enriches at opposite cellular ends. Hundreds of Myo10s are in a typical filopodium, and their distribution across filopodia is log-normal. Some filopodial tips even contain more Myo10 than accessible binding sites on the actin filament bundle. Live-cell movies reveal a dense cluster of over a hundred Myo10 molecules that initiates filopodial elongation. Hundreds of Myo10 molecules continue to accumulate during filopodial growth, but accumulation ceases when retraction begins. Rates of filopodial elongation, second-phase elongation, and retraction are inversely related to Myo10 quantities. Our estimates of Myo10 molecules in filopodia provide insight into the physics of packing Myo10, its cargo, and other filopodia-associated proteins in narrow membrane compartments. Our protocol provides a framework for future work analyzing Myo10 abundance and distribution upon perturbation.

    1. Biochemistry and Chemical Biology
    Megan Larmore, Orhi Esarte Palomero ... Paul G DeCaen
    Research Article

    Ion channels are biological transistors that control ionic flux across cell membranes to regulate electrical transmission and signal transduction. They are found in all biological membranes and their conductive state kinetics are frequently disrupted in human diseases. Organelle ion channels are among the most resistant to functional and pharmacological interrogation. Traditional channel protein reconstitution methods rely upon exogenous expression and/or purification from endogenous cellular sources which are frequently contaminated by resident ionophores. Here, we describe a fully synthetic method to assay functional properties of polycystin channels that natively traffic to primary cilia and endoplasmic reticulum organelles. Using this method, we characterize their oligomeric assembly, membrane integration, orientation, and conductance while comparing these results to their endogenous channel properties. Outcomes define a novel synthetic approach that can be applied broadly to investigate channels resistant to biophysical analysis and pharmacological characterization.